These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19723499)

  • 1. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling.
    Terauchi M; Li JY; Bedi B; Baek KH; Tawfeek H; Galley S; Gilbert L; Nanes MS; Zayzafoon M; Guldberg R; Lamar DL; Singer MA; Lane TF; Kronenberg HM; Weitzmann MN; Pacifici R
    Cell Metab; 2009 Sep; 10(3):229-40. PubMed ID: 19723499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b.
    Li JY; Walker LD; Tyagi AM; Adams J; Weitzmann MN; Pacifici R
    J Bone Miner Res; 2014 Jan; 29(1):43-54. PubMed ID: 24357520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment.
    Robinson JW; Li JY; Walker LD; Tyagi AM; Reott MA; Yu M; Adams J; Weitzmann MN; Pacifici R
    J Bone Miner Res; 2015 Apr; 30(4):695-705. PubMed ID: 25359628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH expands short-term murine hemopoietic stem cells through T cells.
    Li JY; Adams J; Calvi LM; Lane TF; DiPaolo R; Weitzmann MN; Pacifici R
    Blood; 2012 Nov; 120(22):4352-62. PubMed ID: 22955916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Lyu C; Zhang C; Li T; Huang L; Yin X; Zou S
    Int Immunopharmacol; 2019 Dec; 77():105927. PubMed ID: 31679847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression.
    Tyagi AM; Yu M; Darby TM; Vaccaro C; Li JY; Owens JA; Hsu E; Adams J; Weitzmann MN; Jones RM; Pacifici R
    Immunity; 2018 Dec; 49(6):1116-1131.e7. PubMed ID: 30446387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
    Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
    Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid Hormone Shifts Cell Fate of a Leptin Receptor-Marked Stromal Population from Adipogenic to Osteoblastic Lineage.
    Yang M; Arai A; Udagawa N; Zhao L; Nishida D; Murakami K; Hiraga T; Takao-Kawabata R; Matsuo K; Komori T; Kobayashi Y; Takahashi N; Isogai Y; Ishizuya T; Yamaguchi A; Mizoguchi T
    J Bone Miner Res; 2019 Oct; 34(10):1952-1963. PubMed ID: 31173642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells mediate the regenerative PTH effect in hPDL cells via Wnt10b signaling.
    Wolf M; Lossdörfer S; Marciniak J; Römer P; Kirschneck C; Craveiro R; Deschner J; Jäger A
    Innate Immun; 2016 Nov; 22(8):674-681. PubMed ID: 28071181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.
    Pacifici R
    Ann N Y Acad Sci; 2016 Jan; 1364(1):11-24. PubMed ID: 26662934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota.
    Li JY; Yu M; Pal S; Tyagi AM; Dar H; Adams J; Weitzmann MN; Jones RM; Pacifici R
    J Clin Invest; 2020 Apr; 130(4):1767-1781. PubMed ID: 31917685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients.
    D'Amelio P; Sassi F; Buondonno I; Fornelli G; Spertino E; D'Amico L; Marchetti M; Lucchiari M; Roato I; Isaia GC
    Osteoporos Int; 2015 Dec; 26(12):2785-91. PubMed ID: 26068297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone.
    Thouverey C; Caverzasio J
    J Bone Miner Res; 2016 May; 31(5):985-93. PubMed ID: 26643857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
    Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
    J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.
    Datta NS; Kolailat R; Fite A; Pettway G; Abou-Samra AB
    Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.
    Suzuki A; Ozono K; Kubota T; Kondou H; Tachikawa K; Michigami T
    J Cell Biochem; 2008 May; 104(1):304-17. PubMed ID: 17990294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
    Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
    Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.